Hal Kimowitz Inc is categorized under Dentist Offices in Denville, NJ and active since 1975.
Hal Kimowitz Inc was established in 1975, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Dentist Offices business, which does work in the B2B market, and is classified as a Dentist Offices, under code number 6212100 by the NAICS.
If you are seeking more information, feel free to contact Gerrie Ensel, Office Manager at the company’s single location by writing to 75 Bloomfield Avenue # 205, Denville, New Jersey NJ 07834 or by phoning (973) 627-3363. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Hal Kimowitz Inc |
| Contact Person: | Gerrie Ensel, Office Manager |
| Address: | 75 Bloomfield Avenue # 205, Denville, New Jersey 07834 |
| Phone Number: | (973) 627-3363 |
| Website Address: | implantdmd.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1975 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Dentist Offices |
| SIC Code: | 8021 |
| NAICS Code: | 6212100 |
| Share This Business: |
Hal Kimowitz Inc was started in 1975 to provide professional Dentist Offices under the SIC code 8021 and NAICS code 6212100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Gerrie Ensel, Office Manager for inquiries that concern Hal Kimowitz Inc by calling the company number (973) 627-3363, as your correspondence is most welcome. Additionally, the physical location of the single location of Hal Kimowitz Inc can be found at the coordinates 40.89119,-74.47441 as well as the street address 75 Bloomfield Avenue # 205 in Denville, New Jersey 07834.
For its online presence, you may visit Hal Kimowitz Inc’s website at implantdmd.com and engage with its social media outlets through on Twitter and on Facebook.